| Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) (NCT04965597) | Fred Hutchinson Cancer Center | 2022-04-19 |
| AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion (NCT04099966) | Mitchell Cairo | 2021-04-01 |
| The Use of Trifluoperazine in Transfusion Dependent DBA (NCT03966053) | Adrianna Vlachos, MD | 2019-09-13 |
| T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias (NCT03653338) | Paul Szabolcs | 2018-08-02 |
| Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation (NCT03513328) | University of Florida | 2018-06-15 |
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study (NCT03733249) | Bellicum Pharmaceuticals | 2017-01-01 |
| Investigation of the Genetics of Hematologic Diseases (NCT02720679) | St. Jude Children's Research Hospital | 2016-06-17 |
| Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies (NCT02179359) | Masonic Cancer Center, University of Minnesota | 2014-09-02 |
| L-leucine in Diamond Blackfan Anemia Patients (NCT02386267) | Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogache | 2014-09-01 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia (NCT01362595) | Northwell Health | 2013-06-01 |
| Human Placental-Derived Stem Cell Transplantation (NCT01586455) | New York Medical College | 2013-04-01 |
| CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation (NCT01966367) | Diane George | 2013-03-01 |
| Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (NCT01758042) | Massachusetts General Hospital | 2012-11-01 |
| Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01529827) | Roswell Park Cancer Institute | 2012-02-28 |
| Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia (NCT01464164) | Northwell Health | 2012-01-01 |
| Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation (NCT01319851) | Emory University | 2010-09-01 |
| Multi-Center Study of Iron Overload: Survey Study (MCSIO) (NCT01913548) | UCSF Benioff Children's Hospital Oakland | 2010-03-31 |
| Multi-Center Study of Iron Overload: Pilot Study (NCT01114776) | UCSF Benioff Children's Hospital Oakland | 2009-11-01 |
| Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs (NCT00957931) | Stanford University | 2009-03-01 |
| Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload (NCT00673608) | Novartis | 2007-11-01 |
| Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells (NCT02512679) | Children's Hospital Los Angeles | 2007-02-01 |
| Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload (NCT00235391) | Novartis Pharmaceuticals | 2005-10-01 |
| Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias (NCT00244010) | St. Jude Children's Research Hospital | 2005-10-01 |
| Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders (NCT00301834) | University of California, San Francisco | 2005-01-01 |
| Stem Cell Transplant for Hemoglobinopathy (NCT00176852) | Masonic Cancer Center, University of Minnesota | 2002-06-01 |
| Cancer in Inherited Bone Marrow Failure Syndromes (NCT00027274) | National Cancer Institute (NCI) | 2001-11-28 |
| Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia (NCT00011505) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-02-01 |
| Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission (NCT00305708) | University of California, San Francisco | 2000-08-01 |
| Stem Cell Transplant for Bone Marrow Failure Syndromes (NCT00176878) | Masonic Cancer Center, University of Minnesota | 2000-06-01 |
| A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure (NCT00001962) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-11-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628) | Masonic Cancer Center, University of Minnesota | 1999-10-01 |